Literature DB >> 16954699

Genetic variability in CHMP2B and frontotemporal dementia.

Parastoo Momeni1, Ekaterina Rogaeva, Vivianna Van Deerlin, Wuxing Yuan, Jordan Grafman, Michael Tierney, Edward Huey, Jason Bell, Chris M Morris, Rajesh N Kalaria, Susan J van Rensburg, Dana Niehaus, Felix Potocnik, Toshitaka Kawarai, Shabnam Salehi-Rad, Christine Sato, Peter St George-Hyslop, John Hardy.   

Abstract

A nonsense/protein chain-terminating mutation in the CHMP2B gene has recently been reported as a cause of frontotemporal dementia (FTD) in the single large family known to show linkage to chromosome 3. Screening for mutations in this gene in a large series of FTD families and individual patients led to the identification of a protein-truncating mutation in 2 unaffected members of an Afrikaner family with FTD, but not in their affected relatives. The putative pathogenicity of CHMP2B mutations for dementia is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954699     DOI: 10.1159/000094771

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  20 in total

Review 1.  Genetics and underlying pathology of dementia.

Authors:  Beata Ferencz; Lotte Gerritsen
Journal:  Neuropsychol Rev       Date:  2015-01-08       Impact factor: 7.444

2.  CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.

Authors:  Mustapha Ghanim; Léna Guillot-Noel; Florence Pasquier; Ludmila Jornea; Vincent Deramecourt; Bruno Dubois; Isabelle Le Ber; Alexis Brice
Journal:  J Neurol       Date:  2010-07-14       Impact factor: 4.849

3.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

Review 4.  Frontotemporal dementia: from Mendelian genetics towards genome wide association studies.

Authors:  Raffaele Ferrari; John Hardy; Parastoo Momeni
Journal:  J Mol Neurosci       Date:  2011-09-06       Impact factor: 3.444

Review 5.  FTD and ALS: a tale of two diseases.

Authors:  R Ferrari; D Kapogiannis; E D Huey; P Momeni
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 6.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

7.  Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.

Authors:  Hazel Urwin; Astrid Authier; Jorgen E Nielsen; Daniel Metcalf; Caroline Powell; Kristina Froud; Denise S Malcolm; Ida Holm; Peter Johannsen; Jeremy Brown; Elizabeth M C Fisher; Julie van der Zee; Marc Bruyland; Christine Van Broeckhoven; John Collinge; Sebastian Brandner; Clare Futter; Adrian M Isaacs
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

Review 8.  Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

Authors:  Shuo-Chien Ling; Magdalini Polymenidou; Don W Cleveland
Journal:  Neuron       Date:  2013-08-07       Impact factor: 17.173

9.  FUS and TDP43 genetic variability in FTD and CBS.

Authors:  Edward D Huey; Raffaele Ferrari; Jorge H Moreno; Christopher Jensen; Christopher M Morris; Felix Potocnik; Rajesh N Kalaria; Michael Tierney; Eric M Wassermann; John Hardy; Jordan Grafman; Parastoo Momeni
Journal:  Neurobiol Aging       Date:  2011-09-23       Impact factor: 4.673

Review 10.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.